Key facts
- This page summarizes Michael E. Tarvin's Form 4 filing for SELECT MEDICAL HOLDINGS CORP (SEM).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 03 Aug 2021, 16:55.
Michael E. Tarvin - 31 Jul 2021 Form 4 Insider Report for SELECT MEDICAL HOLDINGS CORP (SEM)
- Reporting relationship
- Executive Vice President
- Issuer ticker
- SEM
- Reported as of
- 31 Jul 2021
- Net transaction value
- -$4,020,286
- SEC form
- 4
- Accepted by SEC
- 03 Aug 2021, 16:55:30 UTC
- Next SEC filing
- 05 Aug 2021
- Source filing
- View source filing
- Reporting owner signature
- Michael E. Tarvin
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Michael E. Tarvin filed Form 4 for SELECT MEDICAL HOLDINGS CORP (SEM) on 03 Aug 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: -$4,020,286.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SEM
transaction
Common Stock
Tax liability
- Transaction value
- $1,742,901
- Shares
- -44,180
- Change %
- -12%
- Price
- $39.45
- Shares after
- 313,417
- Date
- 31 Jul 2021
- Ownership
- Direct
- Footnotes
- F1
SEM
transaction
Common Stock
Sale
- Transaction value
- $2,277,385
- Shares
- -57,597
- Change %
- -18%
- Price
- $39.54
- Shares after
- 255,820
- Date
- 02 Aug 2021
- Ownership
- Direct
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Surrender of shares to satisfy tax withholding obligation incident to vesting of restricted stock.
Footnote F2
These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Michael E. Tarvin on September 11, 2020.
Footnote F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.33 to $40.20, inclusive. The reporting person undertakes to provide Select Medical Holdings Corporation, any security holder of Select Medical Holdings Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.